Cost Analysis of Adverse Events Associated with First Line Treatment for Metastatic Renal Cell Carcinoma (MRCC) in the Perspective of Public and Private Health Insurance in Brazil
May 1, 2014, 00:00
10.1016/j.jval.2014.03.443
https://www.valueinhealthjournal.com/article/S1098-3015(14)00494-X/fulltext
Title :
Cost Analysis of Adverse Events Associated with First Line Treatment for Metastatic Renal Cell Carcinoma (MRCC) in the Perspective of Public and Private Health Insurance in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00494-X&doi=10.1016/j.jval.2014.03.443
First page :
A76
Section Title :
Cancer
Open access? :
No
Section Order :
1489